Clinical Trial Update: A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer Patients With Peritoneal Metastasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating a combination of systemic chemotherapy and immune checkpoint inhibitors with hyperthermic intraperitoneal chemotherapy fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Hyperthermic intraperitoneal chemotherapy (HIPEC)
• Immune checkpoint inhibitors (immune checkpoint inhibitor)
• Systemic chemotherapy

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Gastric Cancer | Phase 2 | Status: RECRUITING